{"hands_on_practices": [{"introduction": "Understanding the dynamics of protein turnover is central to cell cycle research. This practice applies the foundational principles of Michaelis-Menten enzyme kinetics to the process of protein degradation mediated by an E3 ligase like the Anaphase-Promoting Complex/Cyclosome (APC/C) [@problem_id:2964434]. By deriving the conditions under which degradation approximates a first-order process, you will connect fundamental kinetic parameters ($K_{M}$, $k_{\\text{cat}}$) to a biologically intuitive measure: the protein's half-life.", "problem": "Cells use the Skp1-Cullin-F-box (SCF) complex and the Anaphase-Promoting Complex/Cyclosome (APC/C) E3 ubiquitin ligases to trigger timely proteolysis of key cell-cycle regulators. Consider a substrate of the APC/C in early anaphase whose degradation is initiated by APC/C-catalyzed polyubiquitination followed by proteasomal destruction. Assume that ubiquitin and ubiquitin-conjugating enzyme are abundant, that polyubiquitination is processive once the substrate is bound, and that the proteasome is not saturated in the time window of interest. Let the active APC/C concentration be $E_{\\text{tot}}=50\\,\\text{nM}$, the catalytic turnover for commitment to degradation be $k_{\\text{cat}}=0.20\\,\\text{s}^{-1}$, and the Michaelis constant for substrate recognition be $K_{M}=5.0\\,\\mu\\text{M}$. The initial substrate concentration is $[S]_{0}=0.50\\,\\mu\\text{M}$.\n\nStarting from the law of mass action and the quasi-steady-state treatment of enzyme-substrate complex formation, derive the conditions under which the time evolution of the substrate concentration $[S](t)$ is well approximated by first-order decay. Under those conditions, determine the effective first-order degradation rate constant $k_{\\text{deg}}$ in terms of $k_{\\text{cat}}$, $E_{\\text{tot}}$, and $K_{M}$, and compute the substrate half-life. Express your final numerical answer for the half-life in minutes, and round to three significant figures.", "solution": "The problem is subjected to validation before any attempt at a solution.\n\n**Step 1: Extracted Givens**\n- System: APC/C E3 ubiquitin ligase and its substrate in early anaphase.\n- Process: APC/C-catalyzed polyubiquitination followed by proteasomal destruction.\n- Assumptions:\n    - Ubiquitin and ubiquitin-conjugating enzyme are abundant.\n    - Polyubiquitination is processive once the substrate is bound.\n    - The proteasome is not saturated.\n- Constants and Initial Conditions:\n    - Active APC/C concentration: $E_{\\text{tot}} = 50\\,\\text{nM}$.\n    - Catalytic turnover rate for commitment to degradation: $k_{\\text{cat}} = 0.20\\,\\text{s}^{-1}$.\n    - Michaelis constant for substrate recognition: $K_{M} = 5.0\\,\\mu\\text{M}$.\n    - Initial substrate concentration: $[S]_{0} = 0.50\\,\\mu\\text{M}$.\n- Required Tasks:\n    - Derive the conditions for first-order decay approximation from the law of mass action and quasi-steady-state treatment.\n    - Determine the effective first-order degradation rate constant $k_{\\text{deg}}$ in terms of $k_{\\text{cat}}$, $E_{\\text{tot}}$, and $K_{M}$.\n    - Compute the substrate half-life in minutes, rounded to three significant figures.\n\n**Step 2: Validation Using Extracted Givens**\nThe problem is scientifically grounded. It describes a standard enzyme kinetics scenario using the Michaelis-Menten framework, a cornerstone of biochemistry and molecular biology. The context of APC/C-mediated protein degradation is a fundamental process in cell cycle control. The provided numerical values for concentrations and kinetic parameters are biologically plausible. The problem is well-posed, providing all necessary information and clear objectives to derive a unique and meaningful solution. The language is objective and precise. The problem does not violate any of the criteria for invalidity.\n\n**Step 3: Verdict and Action**\nThe problem is deemed valid. A complete solution will be provided.\n\n**Solution Derivation**\n\nThe enzymatic reaction, where the APC/C complex ($E$) binds a substrate ($S$) to form a complex ($ES$) and then catalyzes its modification for degradation, can be represented by the following scheme based on the law of mass action:\n$$ E + S \\underset{k_{-1}}{\\stackrel{k_1}{\\rightleftharpoons}} ES \\stackrel{k_{\\text{cat}}}{\\longrightarrow} E + P $$\nHere, $k_1$ is the association rate constant, $k_{-1}$ is the dissociation rate constant, and $k_{\\text{cat}}$ is the catalytic turnover number. $P$ represents the polyubiquitinated substrate, which is irreversibly committed to degradation.\n\nThe rate of substrate consumption, $v$, is given by the rate of product formation:\n$$ v = -\\frac{d[S]}{dt} = k_{\\text{cat}}[ES] $$\nThe problem requires the application of the quasi-steady-state approximation (QSSA) to the enzyme-substrate complex, $[ES]$. This approximation assumes that the concentration of the intermediate $[ES]$ reaches a steady state almost instantaneously, such that its rate of change is zero:\n$$ \\frac{d[ES]}{dt} = k_1 [E][S] - (k_{-1} + k_{\\text{cat}})[ES] \\approx 0 $$\nFrom this, we have:\n$$ k_1 [E][S] = (k_{-1} + k_{\\text{cat}})[ES] $$\nThe total enzyme concentration, $[E]_{\\text{tot}}$, is conserved:\n$$ [E]_{\\text{tot}} = [E] + [ES] \\implies [E] = [E]_{\\text{tot}} - [ES] $$\nSubstituting the expression for the free enzyme concentration $[E]$ into the QSSA equation:\n$$ k_1 ([E]_{\\text{tot}} - [ES])[S] = (k_{-1} + k_{\\text{cat}})[ES] $$\nWe rearrange this equation to solve for $[ES]$:\n$$ k_1 [E]_{\\text{tot}}[S] - k_1 [ES][S] = (k_{-1} + k_{\\text{cat}})[ES] $$\n$$ k_1 [E]_{\\text{tot}}[S] = (k_1 [S] + k_{-1} + k_{\\text{cat}})[ES] $$\n$$ [ES] = \\frac{k_1 [E]_{\\text{tot}}[S]}{k_1 [S] + k_{-1} + k_{\\text{cat}}} $$\nDividing the numerator and denominator by $k_1$ yields:\n$$ [ES] = \\frac{[E]_{\\text{tot}}[S]}{[S] + \\frac{k_{-1} + k_{\\text{cat}}}{k_1}} $$\nThe Michaelis constant, $K_M$, is defined as $K_M = \\frac{k_{-1} + k_{\\text{cat}}}{k_1}$. The problem provides the value of $K_M$ directly. Substituting this definition, we obtain the expression for the steady-state concentration of the enzyme-substrate complex:\n$$ [ES] = \\frac{[E]_{\\text{tot}}[S]}{K_M + [S]} $$\nSubstituting this into the rate equation for substrate consumption gives the Michaelis-Menten equation:\n$$ v = -\\frac{d[S]}{dt} = \\frac{k_{\\text{cat}}[E]_{\\text{tot}}[S]}{K_M + [S]} $$\n\nThe condition for the reaction to be well-approximated by first-order kinetics is that the rate $v$ must be directly proportional to the substrate concentration $[S]$. This occurs when the denominator of the Michaelis-Menten expression, $K_M + [S]$, is approximately constant. Specifically, if the substrate concentration is much lower than the Michaelis constant, $[S] \\ll K_M$, then we can approximate the denominator as $K_M + [S] \\approx K_M$.\nThe given values are $[S]_0 = 0.50\\,\\mu\\text{M}$ and $K_M = 5.0\\,\\mu\\text{M}$. Since $[S]_0 = 0.1 \\times K_M$, the condition $[S] \\ll K_M$ is reasonably satisfied at the beginning of the reaction and becomes an even better approximation as $[S]$ decreases over time.\n\nUnder this condition, $[S] \\ll K_M$, the rate equation simplifies to:\n$$ -\\frac{d[S]}{dt} \\approx \\frac{k_{\\text{cat}}[E]_{\\text{tot}}}{K_M} [S] $$\nThis equation is in the form of a first-order rate law, $-\\frac{d[S]}{dt} = k_{\\text{deg}}[S]$, where $k_{\\text{deg}}$ is the effective first-order degradation rate constant. By comparison, we identify $k_{\\text{deg}}$ as:\n$$ k_{\\text{deg}} = \\frac{k_{\\text{cat}}[E]_{\\text{tot}}}{K_M} $$\nThe solution to the first-order differential equation for substrate concentration $[S](t)$ is an exponential decay:\n$$ [S](t) = [S]_0 \\exp(-k_{\\text{deg}} t) $$\nThe half-life, $t_{1/2}$, is defined as the time at which $[S](t_{1/2}) = \\frac{[S]_0}{2}$.\n$$ \\frac{[S]_0}{2} = [S]_0 \\exp(-k_{\\text{deg}} t_{1/2}) $$\n$$ \\frac{1}{2} = \\exp(-k_{\\text{deg}} t_{1/2}) $$\nTaking the natural logarithm of both sides gives:\n$$ \\ln\\left(\\frac{1}{2}\\right) = -\\ln(2) = -k_{\\text{deg}} t_{1/2} $$\nTherefore, the half-life is:\n$$ t_{1/2} = \\frac{\\ln(2)}{k_{\\text{deg}}} = \\frac{\\ln(2) K_M}{k_{\\text{cat}}[E]_{\\text{tot}}} $$\nNow, we compute the numerical value. The given parameters must be in consistent units. We convert all concentrations to M.\n- $k_{\\text{cat}} = 0.20\\,\\text{s}^{-1}$\n- $[E]_{\\text{tot}} = 50\\,\\text{nM} = 50 \\times 10^{-9}\\,\\text{M} = 5.0 \\times 10^{-8}\\,\\text{M}$\n- $K_M = 5.0\\,\\mu\\text{M} = 5.0 \\times 10^{-6}\\,\\text{M}$\n\nFirst, we calculate the effective rate constant $k_{\\text{deg}}$:\n$$ k_{\\text{deg}} = \\frac{(0.20\\,\\text{s}^{-1})(5.0 \\times 10^{-8}\\,\\text{M})}{5.0 \\times 10^{-6}\\,\\text{M}} = \\frac{1.0 \\times 10^{-8}}{5.0 \\times 10^{-6}}\\,\\text{s}^{-1} = 0.2 \\times 10^{-2}\\,\\text{s}^{-1} = 2.0 \\times 10^{-3}\\,\\text{s}^{-1} $$\nNext, we calculate the half-life in seconds:\n$$ t_{1/2} = \\frac{\\ln(2)}{k_{\\text{deg}}} \\approx \\frac{0.69315}{2.0 \\times 10^{-3}\\,\\text{s}^{-1}} \\approx 346.57\\,\\text{s} $$\nThe problem requires the answer in minutes. We convert seconds to minutes:\n$$ t_{1/2} = 346.57\\,\\text{s} \\times \\frac{1\\,\\text{min}}{60\\,\\text{s}} \\approx 5.7762\\,\\text{min} $$\nRounding to three significant figures, the substrate half-life is $5.78\\,\\text{min}$.", "answer": "$$\\boxed{5.78}$$", "id": "2964434"}, {"introduction": "Cellular pathways are chains of molecular events, and dissecting them requires distinguishing between blocks at different steps. This exercise presents a classic experimental dilemma: how to determine if a failure in protein degradation is due to a problem with the 'tagging' machinery (the APC/C E3 ligase) or the 'disposal' machinery (the proteasome) [@problem_id:2964475]. By analyzing hypothetical experimental data, you will learn to interpret key biochemical signatures that differentiate an upstream ligation failure from a downstream proteolysis block, a critical skill for any molecular biologist.", "problem": "A research team studies how ubiquitin-dependent proteolysis drives mitotic progression in human cells. They focus on the Anaphase-Promoting Complex/Cyclosome (APC/C), an E3 ubiquitin ligase that targets securin and cyclin B for polyubiquitylation at the metaphase-to-anaphase transition, and on the 26S proteasome, which degrades polyubiquitylated substrates. They contrast two perturbations: depletion of Cell Division Cycle 20 (Cdc20), the APC/C co-activator required at metaphase, and acute chemical inhibition of the proteasome with MG132. Cells are synchronized in prometaphase by nocodazole, washed out to allow spindle assembly, and then split into three cohorts: untreated, Cdc20-depleted, or MG132-treated. After release, they quantify the mitotic index $I_M$, the abundance of cyclin B1 and securin, the abundance of K11-linked and K48-linked polyubiquitin chains, and the presence of polyubiquitylated forms of cyclin B1 and securin by denaturing immunoprecipitation followed by anti-ubiquitin immunoblot.\n\nThe following consistent observations are reported at $t = 120\\,\\mathrm{min}$ after nocodazole washout: the mitotic index is high in both perturbations, $I_M^{\\mathrm{Cdc20\\,KD}} \\approx 0.88$ and $I_M^{\\mathrm{MG132}} \\approx 0.85$, compared to untreated $I_M^{\\mathrm{ctrl}} \\approx 0.10$; cyclin B1 and securin remain high in both perturbations relative to control ($\\geq 5$-fold); cohesin cleavage (assayed by Scc1 fragments) is absent in both perturbations; global polyubiquitin conjugates increase markedly only with MG132, with K11-linked chain signal increased $\\sim 5$-fold, K48-linked chains increased $\\sim 3$-fold, whereas Cdc20 depletion shows no increase over control; denaturing immunoprecipitation of cyclin B1 or securin reveals high-molecular-weight polyubiquitin smears only in the MG132 condition; free ubiquitin $[Ub]_{\\mathrm{free}}$ decreases only in MG132; spindle assembly checkpoint kinetochores appear silenced in both perturbations at $t \\approx 60\\,\\mathrm{min}$ (Mad2 negative), yet anaphase onset does not occur.\n\nUsing as fundamental base: (i) the Central Dogma and protein turnover as a balance of synthesis and degradation; (ii) the definition of an E3 ubiquitin ligase as catalyzing covalent attachment of ubiquitin to substrate lysines via E2 enzymes; (iii) the role of APC/C with Cdc20 in initiating anaphase by polyubiquitylating securin and cyclin B, with K11-linked chains a hallmark of APC/C activity; (iv) the role of the 26S proteasome in degrading polyubiquitylated substrates and regenerating free ubiquitin; and (v) the Mitotic Checkpoint Complex (MCC) inhibits APC/C–Cdc20 until proper kinetochore attachment.\n\nWhich option best explains the phenotypic differences between Cdc20 depletion and MG132 treatment and proposes a decisive experimental strategy to distinguish upstream APC/C inhibition from downstream proteolysis blockade?\n\nA. MG132 allows APC/C to remain catalytically active, so APC/C substrates are polyubiquitylated but not degraded, leading to accumulation of high-molecular-weight, K11-linked conjugates on securin and cyclin B and depletion of $[Ub]_{\\mathrm{free}}$. Cdc20 depletion inactivates APC/C at the ubiquitination step, so substrates remain largely non-ubiquitylated at native size. To disentangle upstream versus downstream defects, assay APC/C activity in cells under denaturing conditions by immunoprecipitating securin or cyclin B1 and probing for K11-linked ubiquitin; only a downstream proteolysis block yields robust K11 conjugation. Complement this with MG132 washout: if APC/C had been active upstream, pre-ubiquitylated substrates decay rapidly with an apparent first-order rate constant $k_{\\mathrm{deg}}$ upon proteasome reactivation, whereas no rapid decay occurs if APC/C was inactive due to Cdc20 loss.\n\nB. Both Cdc20 depletion and MG132 equally prevent substrate polyubiquitylation by inhibiting APC/C, but MG132 additionally causes proteotoxic stress. To distinguish upstream from downstream, measure proteasome catalytic activity with a fluorogenic peptide; a reduction in the peptide hydrolysis rate $v$ indicates upstream APC/C inhibition, while unchanged $v$ indicates downstream proteolysis blockade.\n\nC. MG132 specifically blocks Skp1–Cullin–F-box (SCF) E3 ligases but spares APC/C; therefore, cyclin B1 and securin remain unmodified in MG132 but are hyperubiquitylated in Cdc20 depletion due to compensatory APC/C autoubiquitylation. To distinguish mechanisms, quantify K48-linked chains as a specific readout of APC/C activity; increased K48 signal indicates upstream APC/C activation, whereas unchanged K48 indicates downstream proteasome inhibition.\n\nD. Cdc20 depletion hyperactivates the Mitotic Checkpoint Complex and thereby increases proteasome activity, whereas MG132 diminishes Mitotic Checkpoint Complex signaling by preventing turnover of checkpoint proteins. To distinguish sites of action, add a protein phosphatase 2A (PP2A) inhibitor to both conditions to silence the checkpoint; a reduction in mitotic index $I_M$ only in the Cdc20-depleted cells would demonstrate upstream APC/C inhibition.", "solution": "The problem statement must first be validated for scientific integrity and logical consistency.\n\n**Step 1: Extraction of Givens**\n\nThe problem provides the following information:\n*   **System:** Mitotic progression in human cells, focusing on the APC/C E3 ubiquitin ligase and the 26S proteasome.\n*   **Key Molecules:**\n    *   APC/C: E3 ligase targeting securin and cyclin B.\n    *   Cdc20: APC/C co-activator required at metaphase.\n    *   Securin and Cyclin B: APC/C substrates whose degradation is required for anaphase onset.\n    *   26S Proteasome: Degrades polyubiquitylated proteins.\n    *   MG132: A chemical inhibitor of the proteasome.\n    *   Nocodazole: A microtubule-depolymerizing agent used for synchronization in prometaphase.\n*   **Experimental Design:** Cells are synchronized in prometaphase, released from the nocodazole block, and divided into three groups: (1) untreated control, (2) Cdc20-depleted (Cdc20 KD), and (3) MG132-treated.\n*   **Observations at $t = 120\\,\\mathrm{min}$ post-release:**\n    *   Mitotic Index ($I_M$): $I_M^{\\mathrm{ctrl}} \\approx 0.10$; $I_M^{\\mathrm{Cdc20\\,KD}} \\approx 0.88$; $I_M^{\\mathrm{MG132}} \\approx 0.85$.\n    *   Substrate Levels: Cyclin B1 and securin are stable and at high levels ($\\geq 5$-fold over control) in both Cdc20 KD and MG132 conditions.\n    *   Cohesin Cleavage: Absent in both perturbed conditions.\n    *   Global Polyubiquitin: Marked increase in MG132 condition (K11-linked chains $\\sim 5$-fold, K48-linked chains $\\sim 3$-fold); no increase in Cdc20 KD condition.\n    *   Substrate Ubiquitylation: High-molecular-weight polyubiquitin smears on immunoprecipitated cyclin B1/securin are detected *only* in the MG132 condition.\n    *   Free Ubiquitin ($[Ub]_{\\mathrm{free}}$): Decreases *only* in the MG132 condition.\n    *   Spindle Assembly Checkpoint (SAC): Silenced in both perturbed conditions at $t \\approx 60\\,\\mathrm{min}$ (kinetochores are Mad2 negative).\n*   **Fundamental Principles:**\n    *   (i) Protein turnover is a balance of synthesis and degradation.\n    *   (ii) E3 ligases catalyze ubiquitin attachment to substrates.\n    *   (iii) APC/C–Cdc20 polyubiquitylates securin and cyclin B using K11-linked chains to initiate anaphase.\n    *   (iv) The 26S proteasome degrades polyubiquitylated proteins and recycles ubiquitin.\n    *   (v) The Mitotic Checkpoint Complex (MCC) inhibits APC/C–Cdc20.\n\n**Step 2: Validation of Problem Statement**\n\nThe problem is scientifically rigorous and well-posed. The experimental design is standard for cell cycle studies. The provided observations are internally consistent and align perfectly with established molecular mechanisms.\n1.  **Cdc20 Depletion:** Depleting the essential co-activator Cdc20 is expected to render APC/C inactive, even after the SAC is silenced. Without active APC/C, substrates like securin and cyclin B1 are not ubiquitylated and thus not degraded. This leads to a mitotic arrest with high levels of non-ubiquitylated substrates and no change in the global ubiquitin landscape, exactly as reported.\n2.  **MG132 Treatment:** Inhibiting the proteasome blocks the final step of degradation for all ubiquitylated proteins. With the SAC silenced, APC/C–Cdc20 becomes active and polyubiquitylates its targets. These ubiquitylated substrates accumulate because they cannot be degraded. This consumes the pool of free ubiquitin, $[Ub]_{\\mathrm{free}}$, and leads to a massive buildup of polyubiquitylated proteins, including the high-molecular-weight smears of securin and cyclin B1. This also results in a mitotic arrest.\n\nThe data provided are not only plausible but are precisely the expected differential outcomes for an upstream (ligation) block versus a downstream (degradation) block. The problem statement is therefore valid.\n\n**Step 3: Derivation of Solution and Option Analysis**\n\nThe task is to explain the observed differences and identify a decisive experimental strategy. The core distinction lies in the activity state of APC/C and the ubiquitylation status of its substrates. In Cdc20 depletion, the block is upstream of ubiquitylation; APC/C is inactive. In MG132 treatment, the block is downstream of ubiquitylation; APC/C is active, but the proteasome is inactive.\n\nLet us evaluate each option:\n\n**A. MG132 allows APC/C to remain catalytically active, so APC/C substrates are polyubiquitylated but not degraded, leading to accumulation of high-molecular-weight, K11-linked conjugates on securin and cyclin B and depletion of $[Ub]_{\\mathrm{free}}$. Cdc20 depletion inactivates APC/C at the ubiquitination step, so substrates remain largely non-ubiquitylated at native size. To disentangle upstream versus downstream defects, assay APC/C activity in cells under denaturing conditions by immunoprecipitating securin or cyclin B1 and probing for K11-linked ubiquitin; only a downstream proteolysis block yields robust K11 conjugation. Complement this with MG132 washout: if APC/C had been active upstream, pre-ubiquitylated substrates decay rapidly with an apparent first-order rate constant $k_{\\mathrm{deg}}$ upon proteasome reactivation, whereas no rapid decay occurs if APC/C was inactive due to Cdc20 loss.**\n\nThis option provides a flawless summary of the situation. The explanation for both conditions is entirely consistent with the provided data and fundamental principles. MG132 blocks degradation, causing accumulation of ubiquitylated substrates (K11-linked as a hallmark of APC/C) and depletion of free ubiquitin. Cdc20 depletion blocks ubiquitylation itself, so substrates accumulate in their native, unmodified form.\n\nThe proposed experimental strategy is excellent and twofold.\n1.  The denaturing immunoprecipitation followed by immunoblotting for K11-linked ubiquitin on the substrates directly assays the key differential step: whether ubiquitylation has occurred. This is a direct test, and the predicted outcome (signal only in the MG132 case) is correct.\n2.  The MG132 washout experiment is a classic chase experiment. In MG132-treated cells, a pool of ubiquitylated substrates destined for degradation has accumulated. Removing the inhibitor allows the proteasome to act, leading to rapid degradation of this pre-existing pool. In Cdc20-depleted cells, no such pool exists; the substrates are stable and non-ubiquitylated, so washing out MG132 (which was not present in this condition to begin with, but the logic applies to a hypothetical parallel experiment) or simply observing them over time would show no rapid degradation. This is a powerful, dynamic method to distinguish the two states.\n\nConclusion for A: **Correct**.\n\n**B. Both Cdc20 depletion and MG132 equally prevent substrate polyubiquitylation by inhibiting APC/C, but MG132 additionally causes proteotoxic stress. To distinguish upstream from downstream, measure proteasome catalytic activity with a fluorogenic peptide; a reduction in the peptide hydrolysis rate $v$ indicates upstream APC/C inhibition, while unchanged $v$ indicates downstream proteolysis blockade.**\n\nThis option is fundamentally flawed. The initial premise, \"Both Cdc20 depletion and MG132 equally prevent substrate polyubiquitylation,\" is directly contradicted by the experimental data, which show high-molecular-weight polyubiquitin smears on substrates *only* in the MG132 condition. Furthermore, the logic of the proposed experiment is inverted. A reduction in the proteasome's catalytic rate $v$ is the direct signature of a downstream proteolysis blockade (i.e., MG132 treatment), not an upstream APC/C inhibition.\n\nConclusion for B: **Incorrect**.\n\n**C. MG132 specifically blocks Skp1–Cullin–F-box (SCF) E3 ligases but spares APC/C; therefore, cyclin B1 and securin remain unmodified in MG132 but are hyperubiquitylated in Cdc20 depletion due to compensatory APC/C autoubiquitylation. To distinguish mechanisms, quantify K48-linked chains as a specific readout of APC/C activity; increased K48 signal indicates upstream APC/C activation, whereas unchanged K48 indicates downstream proteasome inhibition.**\n\nThis option contains multiple falsehoods. MG132 is a general proteasome inhibitor; it does not selectively block SCF E3 ligases. The statement that cyclin B1 and securin remain unmodified in MG132 is contrary to the provided data. The claim that they are hyperubiquitylated in Cdc20 depletion is also contrary to the data. The idea of \"compensatory APC/C autoubiquitylation\" in this context is speculative and not supported. The proposed experiment is also flawed: K11-linked chains are the hallmark for mitotic APC/C substrates, not K48. Finally, the interpretation is backward; the data show K48 chains increase with the downstream MG132 block, not an upstream event.\n\nConclusion for C: **Incorrect**.\n\n**D. Cdc20 depletion hyperactivates the Mitotic Checkpoint Complex and thereby increases proteasome activity, whereas MG132 diminishes Mitotic Checkpoint Complex signaling by preventing turnover of checkpoint proteins. To distinguish sites of action, add a protein phosphatase 2A (PP2A) inhibitor to both conditions to silence the checkpoint; a reduction in mitotic index $I_M$ only in the Cdc20-depleted cells would demonstrate upstream APC/C inhibition.**\n\nThis option's explanation is inconsistent with both the data and known biology. The data explicitly state the SAC is *silenced* (Mad2 negative), which is the opposite of hyperactivation. Depleting Cdc20 disarms the APC/C, it does not \"hyperactivate\" the MCC. Stabilizing proteins with MG132 would generally be expected to maintain, not diminish, checkpoint signaling, although the data show the checkpoint is off anyway. The experimental proposal is also problematic. A PP2A inhibitor like okadaic acid would generally enhance Cdk1-driven phosphorylation and strengthen, not silence, the checkpoint. The logic of the outcome is also unclear and not a decisive test of the upstream versus downstream block.\n\nConclusion for D: **Incorrect**.\n\nBased on a rigorous analysis, Option A is the only one that correctly interprets the data and proposes valid, decisive experiments. It accurately captures the essence of an upstream versus downstream blockade in a biological pathway.", "answer": "$$\\boxed{A}$$", "id": "2964475"}, {"introduction": "The cell cycle is not just a collection of events, but a highly ordered sequence. This practice explores a fundamental mechanism for achieving temporal control: substrate competition for a limiting regulatory factor [@problem_id:2964476]. Using a simple but powerful equilibrium model, you will derive an expression for the relative degradation rates of two competing APC/C substrates, revealing how differences in concentration and affinity for a coactivator can establish a 'pecking order' for destruction.", "problem": "In cyclin destruction during mitotic exit, the Anaphase Promoting Complex/Cyclosome (APC/C) requires a limiting coactivator (for example, Cdc20 or Cdh1) to recognize substrates via Destruction box (D-box) and KEN-box degron motifs. Consider a minimal, mass-action competition model in which a single pool of coactivator, denoted by $C$, binds reversibly to either a D-box substrate, denoted by $S_{D}$, or a KEN-box substrate, denoted by $S_{K}$. The APC/C core is abundant, such that the rate-limiting step for ubiquitination is coactivator-substrate complex formation and subsequent catalysis. Assume the following:\n\n- The total coactivator concentration is $C_{T}$, conserved on the time scale of interest.\n- Binding is rapid relative to ubiquitin transfer, so that coactivator-substrate binding equilibrates before significant substrate consumption.\n- The binding reactions are $S_{D} + C \\rightleftharpoons S_{D}C$ and $S_{K} + C \\rightleftharpoons S_{K}C$, with dissociation constants $K_{D}^{(D)}$ and $K_{D}^{(K)}$, respectively, defined by $K_{D}^{(D)} = \\frac{[S_{D}][C]}{[S_{D}C]}$ and $K_{D}^{(K)} = \\frac{[S_{K}][C]}{[S_{K}C]}$.\n- Ubiquitination and commitment to degradation occur with catalytic rate constants $k_{D}$ for $S_{D}C$ and $k_{K}$ for $S_{K}C$, respectively, so that instantaneous degradation fluxes are $v_{D} = k_{D}[S_{D}C]$ and $v_{K} = k_{K}[S_{K}C]$.\n- At the initial time, before measurable degradation, the free substrate concentrations are $[S_{D}] = S_{D}^{0}$ and $[S_{K}] = S_{K}^{0}$.\n\nUsing only the law of mass action for binding equilibria and the conservation of total coactivator $C_{T}$, derive an explicit symbolic expression for the ratio of the initial degradation fluxes $\\frac{v_{D}}{v_{K}}$ in terms of $S_{D}^{0}$, $S_{K}^{0}$, $K_{D}^{(D)}$, $K_{D}^{(K)}$, $k_{D}$, and $k_{K}$. Express your final answer as a single simplified closed-form expression. No numerical evaluation is required.", "solution": "The problem presents a scenario of competitive binding of two substrates, $S_{D}$ and $S_{K}$, to a limiting coactivator, $C$, which is necessary for their ubiquitination and subsequent degradation by the APC/C. The objective is to derive the ratio of the initial degradation fluxes, $\\frac{v_{D}}{v_{K}}$. The derivation must be built upon the principles of mass-action kinetics for binding equilibria and the conservation of the total coactivator concentration.\n\nThe initial degradation fluxes for the D-box substrate, $v_{D}$, and the KEN-box substrate, $v_{K}$, are given by the expressions:\n$$v_{D} = k_{D}[S_{D}C]$$\n$$v_{K} = k_{K}[S_{K}C]$$\nwhere $k_{D}$ and $k_{K}$ are the catalytic rate constants for ubiquitination, and $[S_{D}C]$ and $[S_{K}C]$ are the concentrations of the coactivator-substrate complexes.\n\nThe ratio of these fluxes is therefore:\n$$ \\frac{v_{D}}{v_{K}} = \\frac{k_{D}[S_{D}C]}{k_{K}[S_{K}C]} $$\n\nThe problem states that the binding reactions are in rapid equilibrium. This allows us to use the definitions of the dissociation constants, $K_{D}^{(D)}$ and $K_{D}^{(K)}$, to describe the concentrations of the complexes.\nThe equilibrium relationships are:\n$$ K_{D}^{(D)} = \\frac{[S_{D}][C]}{[S_{D}C]} $$\n$$ K_{D}^{(K)} = \\frac{[S_{K}][C]}{[S_{K}C]} $$\nwhere $[S_{D}]$, $[S_{K}]$, and $[C]$ represent the concentrations of the free D-box substrate, free KEN-box substrate, and free coactivator, respectively.\n\nFrom these equilibrium equations, we can express the concentrations of the two complexes in terms of the free species:\n$$ [S_{D}C] = \\frac{[S_{D}][C]}{K_{D}^{(D)}} $$\n$$ [S_{K}C] = \\frac{[S_{K}][C]}{K_{D}^{(K)}} $$\n\nThe problem specifies that we are interested in the *initial* fluxes, at a time before any significant substrate degradation has occurred. At this initial time, the free substrate concentrations are given as $[S_{D}] = S_{D}^{0}$ and $[S_{K}] = S_{K}^{0}$. Let the concentration of free coactivator at this initial equilibrium be denoted as $[C]_{0}$. The concentrations of the complexes at this initial time are thus:\n$$ [S_{D}C]_{0} = \\frac{S_{D}^{0}[C]_{0}}{K_{D}^{(D)}} $$\n$$ [S_{K}C]_{0} = \\frac{S_{K}^{0}[C]_{0}}{K_{D}^{(K)}} $$\n\nThe conservation law for the total coactivator, $C_{T}$, states that the total concentration is the sum of the free coactivator and the coactivator bound to each substrate:\n$$ C_{T} = [C] + [S_{D}C] + [S_{K}C] $$\nApplying this law at the initial time and substituting the equilibrium expressions for the complexes, we get:\n$$ C_{T} = [C]_{0} + \\frac{S_{D}^{0}[C]_{0}}{K_{D}^{(D)}} + \\frac{S_{K}^{0}[C]_{0}}{K_{D}^{(K)}} $$\nThis equation can be rearranged to solve for the initial free coactivator concentration, $[C]_{0}$:\n$$ C_{T} = [C]_{0} \\left( 1 + \\frac{S_{D}^{0}}{K_{D}^{(D)}} + \\frac{S_{K}^{0}}{K_{D}^{(K)}} \\right) $$\n$$ [C]_{0} = \\frac{C_{T}}{1 + \\frac{S_{D}^{0}}{K_{D}^{(D)}} + \\frac{S_{K}^{0}}{K_{D}^{(K)}}} $$\nAlthough the value of $C_{T}$ is not given, its inclusion demonstrates that the system is fully defined and that $[C]_{0}$ is a specific, determinate quantity.\n\nWe now proceed to calculate the ratio of the initial fluxes, $\\frac{v_{D}}{v_{K}}$, by substituting the expressions for the initial complex concentrations, $[S_{D}C]_{0}$ and $[S_{K}C]_{0}$, into the ratio equation:\n$$ \\frac{v_{D}}{v_{K}} = \\frac{k_{D}[S_{D}C]_{0}}{k_{K}[S_{K}C]_{0}} = \\frac{k_{D} \\left( \\frac{S_{D}^{0}[C]_{0}}{K_{D}^{(D)}} \\right)}{k_{K} \\left( \\frac{S_{K}^{0}[C]_{0}}{K_{D}^{(K)}} \\right)} $$\n\nThe term representing the initial free coactivator concentration, $[C]_{0}$, is a common factor in both the numerator and the denominator. As $[C]_{0}$ must be non-zero for any reaction to occur (which requires $C_{T} > 0$), we can cancel it from the expression:\n$$ \\frac{v_{D}}{v_{K}} = \\frac{k_{D} \\frac{S_{D}^{0}}{K_{D}^{(D)}}}{k_{K} \\frac{S_{K}^{0}}{K_{D}^{(K)}}} $$\n\nThis expression represents the ratio of the products of the catalytic rates and the affinity-normalized substrate concentrations. To obtain the final simplified closed-form expression, we rearrange the terms:\n$$ \\frac{v_{D}}{v_{K}} = \\frac{k_{D}}{k_{K}} \\cdot \\frac{S_{D}^{0}}{S_{K}^{0}} \\cdot \\frac{K_{D}^{(K)}}{K_{D}^{(D)}} $$\n\nThis is the required expression. It shows that the relative degradation rate of two competing substrates depends on the ratio of their catalytic efficiencies for degradation ($k_{D}$ vs. $k_{K}$), the ratio of their initial concentrations ($S_{D}^{0}$ vs. $S_{K}^{0}$), and the ratio of their affinities for the common coactivator, noting that a higher affinity corresponds to a lower dissociation constant ($K_{D}$).", "answer": "$$\\boxed{\\frac{k_{D} S_{D}^{0} K_{D}^{(K)}}{k_{K} S_{K}^{0} K_{D}^{(D)}}}$$", "id": "2964476"}]}